Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism GP IIb/IIIa antagonists(Integrin alpha-IIb/beta-3 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thrombosis | Phase 1 | CN | 28 Nov 2018 |